technetium tc 99m hydroxymethylene diphosphonate has been researched along with Secondary Hyperparathyroidism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enevoldsen, LH; Hasbak, P; Heaf, J; Højgaard, L; Zerahn, B | 1 |
| Antón, A; Caballero, O; Martínez, A; Serrano, J; Verdú, J | 1 |
| Brandenburge, S; Han, JK; Magoun, S; Mostowycz, L; Shih, WJ | 1 |
3 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Secondary Hyperparathyroidism
| Article | Year |
|---|---|
Increased technetium-99 m hydroxy diphosphonate soft tissue uptake on bone scintigraphy in chronic kidney disease patients with secondary hyperparathyroidism: correlation with hyperphosphataemia.
Topics: Bone and Bones; Calcium; Coronary Angiography; Durapatite; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Male; Middle Aged; Phosphates; Predictive Value of Tests; Radiopharmaceuticals; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Technetium Tc 99m Medronate; Whole Body Imaging | 2017 |
[Reversible hyperparathyroid metabolic osteopathy secondary to parathyroid carcinoma].
Topics: Bone and Bones; Bone Diseases, Metabolic; Carcinoma; Contrast Media; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Time Factors | 1998 |
Localization of a bone imaging agent in a calcified hematoma.
Topics: Adult; Biopsy; Bone and Bones; Calcinosis; Hematoma; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate | 1999 |